⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL583976 | 0.73 | FDPS (0.56) | — | |
| Pyrophosphoric Acid SCHEMBL8851914 | 0.70 | FDPS (1.00) | — | |
| Peroxymonophosphate SCHEMBL74096 | 0.70 | — | — | |
| Pyrophosphoric Acid SCHEMBL292348 | 0.70 | FDPS (1.00) | — | |
| SCHEMBL309434 | 0.70 | FDPS (0.54) | — | |
| Pyrophosphoric Acid SCHEMBL29634664 | 0.70 | — | — | |
| Pyrophosphoric Acid SCHEMBL3654 | 0.70 | — | — | |
| Pyrophosphoric Acid SCHEMBL23537580 | 0.67 | FDPS (0.91) | — | |
| Peroxymonophosphate SCHEMBL21462088 | 0.67 | — | — | |
| Pyrophosphoric Acid SCHEMBL4346392 | 0.67 | FDPS (0.91) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4836798-B2 | — | — | 2011-12-14 | — | — | JP | claimed |
| EP-1680073-A2 | COMPOUNDS AND METHOD FOR TREATING CANCER | IGF Oncology, LLC (US) | 2006-07-19 | — | — | EP | claimed |
| WO-2005041865-A2 | COMPOUNDS AND METHOD FOR TREATING CANCER | IGF ONCOLOGY, LLC (US) | 2005-05-12 | — | — | WO | claimed |
| US-9011880-B2 | Compounds and methods for treating cancer | IGF ONCOLOGY, LLC (US) | 2015-04-21 | — | — | US | disclosed |
| US-20140171366-A9 | Compounds and methods for treating cancer | IGF ONCOLOGY, LLC | 2014-06-19 | — | — | US | disclosed |
| US-8501906-B2 | Compounds and methods for treating cancer | IGF ONCOLOGY, LLC (US) | 2013-08-06 | — | — | US | disclosed |
| EP-1680073-B1 | COMPOUNDS AND METHOD FOR TREATING CANCER | IGF ONCOLOGY LLC (US) | 2013-01-02 | — | — | EP | disclosed |
| US-20100303929-A1 | Compounds and methods for treating cancer | IGF ONCOLOGY, LLC | 2010-12-02 | — | — | US | disclosed |
| US-7811982-B2 | Compounds and methods for treating cancer | IGF ONCOLOGY, LLC (US) | 2010-10-12 | — | — | US | disclosed |
| US-20100216696-A1 | Compounds and methods for treating cancer | MCTAVISH HUGH | 2010-08-26 | — | — | US | disclosed |
| US-20060258569-A1 | Compounds and methods for treating cancer | IGF ONCOLOGY, LLC | 2006-11-16 | — | — | US | disclosed |
| EP-1680073-A2 | COMPOUNDS AND METHOD FOR TREATING CANCER | IGF Oncology, LLC (US) | 2006-07-19 | — | — | EP | disclosed |
| WO-2005041865-A2 | COMPOUNDS AND METHOD FOR TREATING CANCER | IGF ONCOLOGY, LLC (US) | 2005-05-12 | — | — | WO | disclosed |